company background image
603367 logo

Cisen Pharmaceutical SHSE:603367 Stock Report

Last Price

CN¥14.06

Market Cap

CN¥6.2b

7D

3.1%

1Y

-7.5%

Updated

11 Jul, 2024

Data

Company Financials

Cisen Pharmaceutical Co., Ltd.

SHSE:603367 Stock Report

Market Cap: CN¥6.2b

603367 Stock Overview

Manufactures and sells chemical drug preparations and health care products in China and internationally.

603367 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends4/6

Cisen Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cisen Pharmaceutical
Historical stock prices
Current Share PriceCN¥14.06
52 Week HighCN¥17.45
52 Week LowCN¥11.34
Beta0.16
11 Month Change-9.87%
3 Month Change-7.44%
1 Year Change-7.50%
33 Year Change13.48%
5 Year Change-2.97%
Change since IPO-16.26%

Recent News & Updates

Recent updates

Shareholder Returns

603367CN PharmaceuticalsCN Market
7D3.1%-1.8%-1.7%
1Y-7.5%-17.4%-18.9%

Return vs Industry: 603367 exceeded the CN Pharmaceuticals industry which returned -17.4% over the past year.

Return vs Market: 603367 exceeded the CN Market which returned -18.9% over the past year.

Price Volatility

Is 603367's price volatile compared to industry and market?
603367 volatility
603367 Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 603367 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603367's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19983,402Zhenxin Duwww.lkcisen.com

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company’s chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Co., Ltd. Fundamentals Summary

How do Cisen Pharmaceutical's earnings and revenue compare to its market cap?
603367 fundamental statistics
Market capCN¥6.17b
Earnings (TTM)CN¥528.35m
Revenue (TTM)CN¥4.48b

12.0x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603367 income statement (TTM)
RevenueCN¥4.48b
Cost of RevenueCN¥1.93b
Gross ProfitCN¥2.55b
Other ExpensesCN¥2.02b
EarningsCN¥528.35m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)1.17
Gross Margin56.97%
Net Profit Margin11.80%
Debt/Equity Ratio3.3%

How did 603367 perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

37%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.